Loading chat...
TN SB1495
Bill
Status
2/19/2026
Primary Sponsor
Ferrell Haile
Click for details
AI Summary
-
Adds three pharmaceutical companies—Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc.—to existing opioid-related statutory provisions that previously only named Purdue Pharma L.P.
-
Amends Tennessee Code Section 20-13-203 (Title 20, Civil Procedure) to include the additional companies
-
Amends Tennessee Code Section 33-11-103(p) (Title 33, Mental Health) to include the additional companies
-
Takes effect immediately upon becoming law due to public welfare necessity
-
Contains a severability clause ensuring remaining provisions stay in effect if any part is held invalid
Legislative Description
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
Opioids
Last Action
Rcvd. from S., held on H. desk.
2/23/2026